Prevention of emergence delirium after sevoflurane anesthesia in children

Prevention of emergence delirium after sevoflurane anesthesia in children: Dexmedetomidine versus midazolam in caudal block. A prospective randomized double blinded study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202203663979478

Enrollment

Registered

2022-03-16

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

bupivacaine

bupivacaine and midazolam

bupivacaine and dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: child aged 2-6 years American Society of Anesthesiologists (ASA) physical status I or II undergoing lower abdominal or perineal surgeries under general anesthesia

Exclusion criteria

Exclusion criteria: pediatric patients known to have coagulopathies, neurological, neuromuscular, or spinal diseases mental retardation signs of infection at the caudal region history of study drug allergy

Design outcomes

Primary

Measure	Time frame
the degree of emergence delirium	—

Secondary

Measure	Time frame
hemodynamics, pain scoring, dexmedetomidine and fentanyl requirements, and duration of post-anesthesia care unit stay	—

Countries

Egypt

Contacts

Public ContactMohamed Ali

Department of Anesthesia Faculty of Medicine Ain Shams University

mohamed_mourad@med.asu.edu.eg+201006512101

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026